Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTIX | AMGN | VRTX | REGN | BMY |
| Company | Protagenic Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.5300 | 306.42 | 451.90 | 984.04 | 41.41 |
| High | 1.7000 | 307.50 | 457.66 | 995.41 | 41.68 |
| Low | 1.5200 | 303.90 | 449.42 | 983.16 | 41.07 |
| Last | 1.5600 | 305.84 | 456.95 | 985.02 | 41.24 |
| Change | -0.1100 | -0.66 | +6.15 | +4.45 | -0.30 |
| % Change | -6.59% | -0.22% | +1.36% | +0.45% | -0.72% |
| Volume | 35,200 | 2,425,800 | 1,050,900 | 259,200 | 17,425,500 |
| 20-Day Average Volume | 21,785 | 2,868,870 | 1,162,315 | 425,045 | 13,726,615 |
| Previous Close | 1.6700 | 306.50 | 450.80 | 980.57 | 41.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4085 | 303.24 | 424.54 | 961.40 | 43.75 |
| 20-Day Raw Stochastic | 52.36% | 68.74% | 98.92% | 88.79% | 3.66% |
| 20-Day Relative Strength | 54.36% | 57.73% | 74.37% | 59.92% | 25.57% |
| Weighted Alpha | +7.56 | +36.96 | +40.81 | +35.05 | -38.39 |
| Today's Opinion | 72% Buy | 88% Buy | 88% Buy | 88% Buy | 100% Sell |
| Previous Opinion | 72% Buy | 88% Buy | 88% Buy | 88% Buy | 100% Sell |
| Last Month's Opinion | 64% Buy | 72% Sell | 8% Buy | 8% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.99% since 05/17/24 | -2.12% since 05/17/24 | +2.64% since 05/17/24 | +0.28% since 05/17/24 | -6.34% since 05/17/24 |
| Low | 1.3201 on 05/20/24 | 303.90 on 05/24/24 | 437.46 on 05/21/24 | 975.73 on 05/23/24 | 41.07 on 05/24/24 |
| High | 1.8700 on 05/22/24 | 316.67 on 05/21/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 44.04 on 05/20/24 |
| 1-Month | |||||
| %Chg | -4.76% since 04/24/24 | +12.03% since 04/24/24 | +14.02% since 04/24/24 | +8.66% since 04/24/24 | -15.60% since 04/24/24 |
| Low | 1.2193 on 05/08/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 41.07 on 05/24/24 |
| High | 1.8700 on 05/22/24 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 47.50 on 04/25/24 |
| 3-Month | |||||
| %Chg | +75.97% since 02/23/24 | +5.76% since 02/23/24 | +6.24% since 02/23/24 | +0.39% since 02/23/24 | -20.17% since 02/23/24 |
| Low | 0.8800 on 02/29/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 41.07 on 05/24/24 |
| High | 1.8700 on 05/22/24 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +92.59% since 11/22/23 | +15.21% since 11/24/23 | +29.43% since 11/24/23 | +23.39% since 11/24/23 | -17.12% since 11/24/23 |
| Low | 0.6797 on 12/04/23 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 41.07 on 05/24/24 |
| High | 1.8700 on 05/22/24 | 329.72 on 02/05/24 | 457.66 on 05/24/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,919 | 164,063,280 | 117,917,328 | 108,535,408 | 83,597,608 |
| Shares Outstanding, K | 4,435 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -5,000,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,720,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.44 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 04/01/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/27/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.45 | 29.93 | 26.42 | 39.56 |